UBS Group AG - ENZON PHARMACEUTICALS INC ownership

ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 56 filers reported holding ENZON PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ENZON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$340,000
-28.3%
723,072
+4.2%
0.00%
Q4 2015$474,000
-34.3%
694,026
-6.6%
0.00%
-100.0%
Q3 2015$721,000
-15.2%
743,207
+5.0%
0.00%0.0%
Q2 2015$850,000
+13.0%
707,921
-0.2%
0.00%0.0%
Q1 2015$752,000
-2.5%
709,021
+0.2%
0.00%0.0%
Q4 2014$771,000707,9510.00%
Other shareholders
ENZON PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Ancora Advisors LLC 50,000$20,0000.00%
MONARCH CAPITAL MANAGEMENT INC/ 10,000$4,0000.00%
ACADIAN ASSET MANAGEMENT LLC 122,287$50,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 254,200$103,0000.00%
TUDOR INVESTMENT CORP ET AL 47,998$19,0000.00%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 11,181$5,0000.00%
Kistler-Tiffany Companies, LLC 825$00.00%
Tradewinds Capital Management, LLC 200$00.00%
NEXT Financial Group, Inc 60$00.00%
CT Financial Advisors LLC 2,000$810,0000.00%
View complete list of ENZON PHARMACEUTICALS INC shareholders